Helix PartnersMUSC and Helix launch In Our DNA SC, first-of-its-kind population genomics program to drive preventive, precision health care for South CaroliniansSeptember 20, 2021
Helix PartnersHelix Study Identifies Additional Genes for Population Genetic ScreeningAugust 18, 2021
Helix PartnersPositive predictive value highlights four novel candidates for actionable genetic screening from analysis of 220,000 clinicogenomic recordsAugust 12, 2021
Helix PartnersComprehensive allele genotyping in critical pharmacogenes reduces residual clinical risk in diverse populationsApril 30, 2021
Public HealthHelix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.April 8, 2021
Public HealthHelix Launches a COVID-19 Viral Surveillance Dashboard to Track Emergence and Prevalence of New SARS-CoV-2 VariantsJanuary 21, 2021
Public HealthIllumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance InfrastructureJanuary 15, 2021
Helix PartnersPathogenic variants in actionable MODY genes are associated with type 2 diabetesOctober 11, 2020
Public HealthGenomics startup Helix receives $33 million in NIH funding to scale COVID-19 testingJuly 31, 2020
Public HealthHelix partners with San Diego County to make COVID-19 testing accessible for those who need it mostJuly 13, 2020
Helix PartnersSaliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community settingMay 15, 2020
